(Q37997046)

26 August 2017

title

Efficacy and pharmacogenomic biomarkers in breast cancer (English)

1 reference

26 August 2017

0 references

1 reference

2

Richard B Schwab

1 reference

26 August 2017

Asit K Paul

1

1 reference

26 August 2017

publication date

1 April 2012

1 reference

26 August 2017

published in

Biomarkers in Medicine

1 reference

26 August 2017

volume

6

1 reference

26 August 2017

issue

2

1 reference

26 August 2017

page(s)

211-221

1 reference

Contribution of biomarkers to personalized medicine

26 August 2017

cites work

1 reference

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

21 January 2018

1 reference

Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers

21 January 2018

1 reference

Reporting recommendations for tumor marker prognostic studies (REMARK).

21 January 2018

1 reference

NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.

21 January 2018

1 reference

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

21 January 2018

1 reference

Emerging biomarkers in breast cancer care

21 January 2018

1 reference

Predicting Response to Endocrine Therapy in Human Breast Cancer: A Hypothesis

21 January 2018

1 reference

American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

21 January 2018

1 reference

NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry

21 January 2018

1 reference

Predictive algorithms for adjuvant therapy: TransATAC.

21 January 2018

1 reference

Estrogen receptors: role in breast cancer.

21 January 2018

1 reference

Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience

21 January 2018

1 reference

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

21 January 2018

1 reference

Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17.

21 January 2018

1 reference

Current status of estrogen receptors in human breast cancer

21 January 2018

1 reference

Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status

21 January 2018

1 reference

Progesterone Receptor Status Significantly Improves Outcome Prediction Over Estrogen Receptor Status Alone for Adjuvant Endocrine Therapy in Two Large Breast Cancer Databases

21 January 2018

1 reference

Recent advances in systemic therapy: new diagnostics and biological predictors of outcome in early breast cancer.

21 January 2018

1 reference

Progesterone antagonists and progesterone receptor modulators in the treatment of breast cancer

21 January 2018

1 reference

Single-injection depot progesterone before surgery and survival in women with operable breast cancer: a randomized controlled trial

21 January 2018

1 reference

Does the timing of breast cancer surgery in pre-menopausal women affect clinical outcome? An update

21 January 2018

1 reference

Control of mammary stem cell function by steroid hormone signalling.

21 January 2018

1 reference

Amplification of a novel v-erbB-related gene in a human mammary carcinoma

21 January 2018

1 reference

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer

21 January 2018

1 reference

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

Adjuvant endocrine therapy in hormone receptor-positive postmenopausal breast cancer: evolution of NCCN, ASCO, and St Gallen recommendations

21 January 2018

1 reference

Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations

21 January 2018

1 reference

Molecular predictors of response to trastuzumab and lapatinib in breast cancer.

21 January 2018

1 reference

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

21 January 2018

1 reference

Association between gain-of-function mutations in PIK3CA and resistance to HER2-targeted agents in HER2-amplified breast cancer cell lines

21 January 2018

1 reference

PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients.

21 January 2018

1 reference

Lapatinib plus capecitabine for HER2-positive advanced breast cancer

21 January 2018

1 reference

Single-agent lapatinib for HER2-overexpressing advanced or metastatic breast cancer that progressed on first- or second-line trastuzumab-containing regimens

21 January 2018

1 reference

Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer

21 January 2018

1 reference

Lapatinib combined with letrozole versus letrozole and placebo as first-line therapy for postmenopausal hormone receptor-positive metastatic breast cancer

21 January 2018

1 reference

Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the Arimidex, Tamoxifen, Alone or in Combination trial

21 January 2018

1 reference

Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer

21 January 2018

1 reference

HER2/neu in systemic therapy for women with breast cancer: a systematic review

21 January 2018

1 reference

Alteration of topoisomerase II-alpha gene in human breast cancer: association with responsiveness to anthracycline-based chemotherapy

21 January 2018

1 reference

Gene-expression signatures in breast cancer

21 January 2018

1 reference

Prognostic applications of gene expression signatures in breast cancer

21 January 2018

1 reference

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

21 January 2018

1 reference

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

21 January 2018

1 reference

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009

21 January 2018

1 reference

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer

21 January 2018

1 reference

Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).

21 January 2018

1 reference

Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signature.

21 January 2018

1 reference

Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design

21 January 2018

1 reference

Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation

21 January 2018

1 reference

Measuring proliferation in breast cancer: practicalities and applications

21 January 2018

1 reference

Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections

21 January 2018

1 reference

Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value

21 January 2018

1 reference

Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.

21 January 2018

1 reference

Ki67 in breast cancer: prognostic and predictive potential

21 January 2018

1 reference

p53 protein accumulation predicts resistance to endocrine therapy and decreased post-relapse survival in metastatic breast cancer.

21 January 2018

1 reference

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial

21 January 2018

1 reference

Circulating tumor cells and emerging blood biomarkers in breast cancer

21 January 2018

1 reference

Detection of breast cancer cells in the peripheral blood is positively correlated with estrogen-receptor status and predicts for poor prognosis

21 January 2018

1 reference

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

21 January 2018

1 reference

Detection of mutations in EGFR in circulating lung-cancer cells

21 January 2018

1 reference

Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers

21 January 2018

1 reference

Pharmacogenetics in breast cancer therapy

21 January 2018

1 reference

Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes

21 January 2018

1 reference

Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen

21 January 2018

1 reference

Genotype-guided tamoxifen therapy: time to pause for reflection?

21 January 2018

1 reference

Tamoxifen metabolite concentrations, CYP2D6 genotype, and breast cancer outcomes.

21 January 2018

1 reference

Human aromatase: gene resequencing and functional genomics

21 January 2018

1 reference

A single-nucleotide polymorphism in the aromatase gene is associated with the efficacy of the aromatase inhibitor letrozole in advanced breast carcinoma

21 January 2018

1 reference

HER2 and Response to Paclitaxel in Node-Positive Breast Cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/BMM.12.7

1 reference

26 August 2017

1 reference